Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, Toda M: Chemokines: roles in leukocyte development, trafficking and effector function.
J Allergy Clin Immunol 2003, 111:1185–1199.
Sanz MJ, Kubes P: Neutrophil-active chemokines in in vivo imaging of neutrophil trafficking.
Eur J Immunol 2012, 42:278–283.
Lira SA, Furtado GC: The biology of chemokines and their receptors.
Immunol Res 2012, 54:111–120.
Smith JJ, Lukacs NW: A closer look at chemokines and their role in asthmatic responses.
Eur J Pharmacol 2006, 3:277–288.
Vestergaard C, Deleuran M, Gesser B, Gronhoj LC: Expression of the T-helper 2-specific chemokine receptor CCR4 on CCR10-positive lymphocytes in atopic dermatitis skin but not in psoriasis skin.
Br J Dermatol 2003, 149:457–463.
Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Komine M, Asahina A, Tamaki K: Serum macrophage derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis.
Clin Exp Immunol 2002, 12:270–273.
Mantovani A, Gray PA, van Damme J, Sozzani S: Macrophage-derived chemokine (MDC).
J Leukoc Biol 2000, 68:400–404.
Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O: The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4.
J Biol Chem 1997, 272:15036–15042.
Kunkel EJ, Boisvert J, Murphy K, Vierra MA, Genovese MC, Wardlaw AJ, Greenberg HB, Hodge MR, Wu L, Butcher EC, Campbell JJ: Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue infiltrating lymphocytes.
Am J Pathol 2002, 160:347–355.
Bhowmick S, Chatterjee D, Chaudhuri K: Human epithelial cells stimulated with Vibrio cholerae produce thymic stromal lymphopoietin and promote dendritic cell-mediated inflammatory Th2 response.
Int J Biochem Cell Biol 2012, 44:1779–1790.
Abrahamsson TR, Sandberg Abelius M, Forsberg A, Björkstén B, Jenmalm MC: A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization.
Clin Exp Allergy 2011, 41:1729–1739.
Oliphant CJ, Barlow JL, McKenzie AN: Insights into the initiation of type 2 immune responses.
Immunology 2011, 134:378–385.
Machura E, Rusek-Zychma M, Jachimowicz M, Wrzask M, Mazur B, Kasperska-Zajac A: Serum TARC and CTACK concentrations in children with atopic dermatitis, allergic asthma, and urticaria.
Pediatr Allergy Immunol 2012, 23:278–284.
Abelius MS, Ernerudh J, Berg G, Matthiesen L, Nilsson LJ, Jenmalm MC: High cord blood levels of the T-helper 2-associated chemokines CCL17 and CCL22 precede allergy development during the first 6 years of life.
Pediatr Res 2011, 70:495–500.
Okamoto H, Koizumi K, Yamanaka H, Saito T, Kamatani N: A role for TARC/CCL17, a CC chemokine, in systemic lupus erythematosus.
J Rheumatol 2003, 30:2369–2373.
Fujii H, Shimada Y, Hasegawa M, Takehara K, Sato S: Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis.
J Dermatol Sci 2004, 35:43–51.
Galimberti D, Fenoglio C, Comi C, Scalabrini D, De Riz M, Leone M, Venturelli E, Cortini F, Piola M, Monaco F, Bresolin N, Scarpini E: MDC/CCL22 intrathecal levels in patients with multiple sclerosis.
Mult Scler 2008, 14:547–549.
Galimberti D, Scalabrini D, Fenoglio C, De Riz M, Comi C, Venturelli E, Cortini F, Piola M, Leone M, Dianzani U, D’Alfonso S, Monaco F, Bresolin N, Scarpini E: Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to multiple sclerosis.
J Neurol Sci 2008, 267:86–90.
Karpus WJ, Fife BT, Kennedy KJ: Immunoneutralization of chemokines for the prevention and treatment of central nervous system autoimmune disease.
Methods 2003, 29:362–368.
Karpus WJ, Ransohoff RM: Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis.
J Immunol 1998, 161:2667–2671.
Cohly HH, Panja A: Immunological findings in autism.
Int Rev Neurobiol 2005, 71:317–341.
Singh VK, Warren RP, Averett R, Ghaziuddin M: Circulating autoantibodies to neuronal and glial filament proteins in autism.
Pediatr Neurol 1997, 17:88–90.
Mostafa GA, El-Sayed ZA, Abd El Aziz MM, El-Sayed MF: Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children.
J Child Neurol 2008, 23:1413–1418.
Mostafa GA, Al-Ayadhi LY: Increased serum levels of anti-ganglioside M1 auto-antibodies in autistic children: relation to the disease severity.
J Neuroinflammation 2011, 8:39.
Mostafa GA, Al-Ayadhi LY: A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children.
J Neuroinflammation 2011, 8:71.
Mostafa GA, Al-Ayadhi LY: The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism.
J Neuroinflammation 2011, 8:180.
Al-Ayadhi LY, Mostafa GA: A lack of association between elevated serum levels of S100B protein and autoimmunity in autistic children.
J Neuroinflammation 2012, 9:54.
Mostafa GA, Al-Ayadhi LY: The relationship between the increased frequency of serum antineuronal antibodies and the severity of autism in children.
Eur J Paediatr Neurol 2012, 16:464–468.
Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ: Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders.
Pediatrics 2003, 112:420–424.
Mostafa GA, Kitchener N: Serum anti-nuclear antibodies as a marker of autoimmunity in Egyptian autistic children.
Pediatr Neurol 2009, 40:107–112.
Mostafa GA, Shehab A: The link of C4B null allele to autism and to a family history of autoimmunity in Egyptian autistic children.
J Neuroimmunol 2010, 223:115–119.
Mostafa GA, Al Shehab A, Fouad NR: Increased frequency of CD4 + CD25high regulatoryT cells in the peripheral blood of Egyptian children with autism.
J Child Neurol 2010, 25:328–335.
Mostafa GA, El-Hadidi ES, Hewedi DH, Abdou MM: Oxidative stress in Egyptian children with autism: relation to autoimmunity.
J Neuroimmunol 2010, 219:114–118.
American Psychiatric Association: Diagnostic and statistical manual of mental disorders. 4th edition. Washington DC: American Psychiatric Association; 1994.
Schopler E, Reichler RJ, Renner BR: The childhood autism rating scale (CARS), for diagnostic screening and classification in autism. New York. NY: Irvington; 1986.
Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA: Neuroglial activation and neuroinflammation in the brain of patients with autism.
Ann Neurol 2005, 57:67–81.
Suzuki K, Matsuzaki H, Iwata K, Kameno Y, Shimmura C, Kawai S, Yoshihara Y, Wakuda T, Takebayashi K, Takagai S, Matsumoto K, Tsuchiya KJ, Iwata Y, Nakamura K, Tsujii M, Sugiyama T, Mori N: Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders.
PLoS One 2011, 6:e20470.
Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water JJ: Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders.
Neuroimmunol 2011, 232:196–199.
Manzardo AM, Henkhaus R, Dhillon S, Butler MG: Plasma cytokine levels in children with autistic disorder and unrelated siblings.
Int J Dev Neurosci 2012, 30:121–127.
Abdallah MW, Larsen N, Grove J, Nørgaard-Pedersen B, Thorsen P, Mortensen EL, Hougaard DM: Amniotic fluid chemokines and autism spectrum disorders: an exploratory study utilizing a Danish historic birth cohort.
Brain Behav Immun 2012, 26:170–176.
Hirata H, Arima M, Cheng G, Honda K, Fukushima F, Yoshida N, Eda F, Fukuda T: Production of TARC and MDC by naive T cells in asthmatic patients.
J Clin Immunol 2003, 23:34–45.
Zlotnik A, Yoshie O: Chemokines: a new classification system and their role in immunity.
Immunity 2000, 12:121–127.
Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC: CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin.
J Exp Med 2001, 194:1541–1547.
Pinho V, Oliveira SH, Souza DG, Vasconcelos D, Alessandri AL, Lukacs NW, Teixeira MM: The role of CCL22 (MDC) for the recruitment of eosinophils during allergic pleurisy in mice.
J Leukoc Biol 2003, 73:356–362.
Minshall EM, Cameron L, Lavigne F, Leung DY, Hamilos D, Garcia-Zepada EA, Rothenberg M, Luster AD, Hamid Q: Eotaxin mRNA and protein expression in chronic sinusitis and allergen induced nasal responses in seasonal allergic rhinitis.
Am J Respir Cell Mol Biol 1997, 17:683–690.
Proost P, Wuyts A, Van Damme J: Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1.
J Leukoc Biol 1996, 59:67–74.
Sebastiani S, Danelon G, Gerber B, Uguccioni M: CCL22-induced responses are powerfully enhanced by synergy inducing chemokines via CCR4. evidence for the involvement of first beta-strand of chemokine.
Eur J Immunol 2005, 35:746–756.
Heiseke AF, Faul AC, Lehr HA, Förster I, Schmid RM, Krug AB, Reindl W: CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cell-mediated protection from colitis.
Gastroenterology 2012, 142:335–345.
Jadidi-Niaragh F, Mirshafiey A: Th17 Cell, the new player of neuroinflammatory process in multiple sclerosis.
Scand J Immunol 2011, 74:1–13.
Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, Antoni C, Draelos Z, Gold MH, Durez P, Tak PP, Gomez-Reino JJ, Foster CS, Kim RY, Samson CM, Falk NS, Chu DS, Callanan D, Nguyen QD, Rose K, Haider A, Di Padova F, Psoriasis Study Group: Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.
Sci Transl Med 2010, 2:52–72.
Vignali DA, Collison LW, Workman CJ: How regulatory T cells work.
Nat Rev Immunol 2008, 8:523–532.
Al-Ayadhi LY, Mostafa GA: Elevated serum levels of interleukin-17A in children with autism.
J Neuroinflammation 2012, 9:158.
Alam R, Busse WW: The eosinophil-quo vadis?
J Allergy Clin Immunol 2004, 113:8–42.